Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91af2c7d5c9289773eb48a6cbe1b12a3 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147 |
filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d5e4bcccb89f60cba27842ee4aad11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f15d42eccd2a38d9ccc6480b9a12116 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432c676a66efbac379e322c08951cb5b |
publicationDate |
2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20190044366-A |
titleOfInvention |
Novel benzopyranyl tetracycle compound and pharmaceutical composition having excellent anti-inflammatory effect comprising the same |
abstract |
The present invention relates to novel compounds of the following formula (3j) or (5) (2l), and pharmaceutical compositions having excellent antiinflammatory effects comprising the same. These compounds inhibit the migration of the HMGB1 protein, which is an inflammation-inducing factor, from the nucleus to the cytoplasm, thereby having an excellent inflammation-inhibiting effect, and particularly, an excellent therapeutic or preventive effect against sepsis. (3) [Chemical Formula 5] |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023277656-A1 |
priorityDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |